CTRI/2020/02/023495尚未招募未知
A prospective observational study on the efficacy and side effects of oral KUVA ( khellin UV A) SOL therapy in stable vitiligo patients.
Dr Lavin Bhatia0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Patients with stable lesions.
- •2.Patients between 18 and 60 years of age.
- •3.Patients who give informed consent for the study and photography.
- •4.Patients who can follow up in the opd
排除标准
- •1.Patients who are unwilling to participate in the study.
- •2.Patients who had used any topical treatment 2 weeks and systemic treatment 4 weeks before starting on KUVA SOL.
- •3.Patients with history of photosensitive disorders, skin cancer, hepatic or renal disease and lesions over genitals.
- •4.Pregnant or lactating women.
- •5.Unstable vitiligo.
- •6.Patients with spontaneous repigmentation of depigmented macules.
研究者
相似试验
招募中
不适用
A prospective observational study on the efficacy of switching to sertraline in depressive patients who failed treatment with duloxetinemajor depressive disorderJPRN-UMIN000009609Tokyo Womens Medical University100
招募中
不适用
The efficacy and safety of the Gefapixant in patients with interstitial lung diseaseinterstitial lung diseaseJPRN-jRCT1031220275Abe Mitsuhiro30
已完成
不适用
A group study for outcomes to see if freezing nerves with local anaesthetics can be used for collarbone surgeries.CTRI/2021/05/033826KPC Medical College Hospital30
未知
Unknown
A prospective observational study of the efficacy and safety of CPT-11 based regimens (CPT-11+platinum analogues) for UGT1A1 genotype guided patientsSmall cell lung cancer, non-small cell lung cancer, cervical cancer, ovarian cancer and gastric cancer (inoperable or recurrent)JPRN-jRCT1080220914DAIICHI SANKYO COMPANY, LIMITED1,000
未知
Unknown
A prospective observational study of the efficacy and safety of CPT-11 based regimens for UGT1A1 genotype guided patients with metastatic colorectal cancerMetastatic colorectal cancer (adenocarcinoma)JPRN-jRCT1080220913DAIICHI SANKYO COMPANY, LIMITED2,000